Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BI 201335
BI 201335
Boehringer Ingelheim Hepatitis C Drugs Cured 82% in Trial
Bloomberg
Thu, 04/19/12 - 10:36 am
Boehringer Ingelheim
hepatitis C
BI 201335
protease inhibitors
nucleoside polymerase inhibitor
BI 207127
